Castle Biosciences(CSTL) Presents New Data Demonstrating DecisionDx-SCC Complements Current Risk Assessment Methods in Patients with SCC of the Head and Neck
Go back to Castle Biosciences(CSTL) Presents New Data Demonstrating DecisionDx-SCC Complements Current Risk Assessment Methods in Patients with SCC of the Head and Neck| Castle Technologies, Inc. (NASDAQ: CSTL) | Delayed: 19.86 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $19.86 | 52 Week High | $3.92 | |||
| Open | $19.86 | 52 Week Low | $0.00 | |||
| Day High | $19.86 | P/E | N/A | |||
| Day Low | $19.86 | EPS | $0.00 | |||
| Volume | 5 | |||||
